Akèy › Sipwa › Kalifòni › Huntington Beach

Etid klinik pou Sipwa nan Huntington Beach, CA

5 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Huntington Beach (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3

Ark Clinical Research - Fountain Valley, Fountain Valley · 4 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Ap rekriteFaz 3

Ark Clinical Research - Fountain Valley, Fountain Valley · 4 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07353931

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Ap rekriteFaz 3Volontè an sante akeyi

ACCOMPLISH-2 Research Site, Fountain Valley · 4 mi lwen

Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Ap rekriteFaz 4

First OC Dermatology Research Inc, Fountain Valley · 4 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06857942

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3

Ark Clinical Research- Tustin, Fountain Valley · 4 mi lwen

Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235

Etid Sipwa nan lòt vil

Lòt etid nan Huntington Beach

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.